The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD), for the treatment of immune thrombocytopenia.... Nov 20
Principia’s Bruton tyrosine kinase (BTK) inhibitors add to Sanofi’s efforts of transformative treatments for autoimmune diseases... Aug 17
-Advertisements-